TY - JOUR
T1 - Adrenergic receptor subtypes in rabbit iris-ciliary body membranes
T2 - Classification by radioligand studies
AU - Mittag, Thomas W.
AU - Tormay, Anne
N1 - Funding Information:
This research was supported National Eye Institute/NIH. 1 To whom all correspondence
PY - 1985/2
Y1 - 1985/2
N2 - Receptor subclasses in iris-ciliary body cell membranes were determined by direct binding of radioactive dihydroalprenolol (DHA), yohimbine (YOH), WB-4101 (WB) and prazosin (PRZ), classified respectively as β1 + β2, α2, α1, and α1 subtype selective ligands (based on binding to brain adrenergic receptors). Specific binding was defined with appropriate unlabelled agonist and antagonist drugs in each case. Binding data were analysed by library programs of the PROPHET computer system. Subclass specificity was also determined indirectly by binding competition of the labelled ligand (at a three- to 10-fold Kd concentration) with increasing concentrations of 'cold' agonist or antagonist. Ligand binding parameters of unlabelled drugs were obtained from Dixon and Scatchard plots of the data. The adrenergic receptor density of iris-ciliary body is approx. 600 fmol mg-1 protein, of which 20-25% are primarily β2 receptors. Three distinct subpopulations of α-receptors, representing 10, 25 and 40-45% of the total, bind PRZ, WB and YOH, respectively, each with high specificity for its corresponding ligand but with 10- to 1000-fold lower specificity for the other two ligands. The majority of α-adrenergic receptors are of the α2-subtype. A small population of receptors are similar to vascular postsynaptic α1-receptors, while a larger subpopulation may have characteristics intermediate between α1- and α2-subtypes.
AB - Receptor subclasses in iris-ciliary body cell membranes were determined by direct binding of radioactive dihydroalprenolol (DHA), yohimbine (YOH), WB-4101 (WB) and prazosin (PRZ), classified respectively as β1 + β2, α2, α1, and α1 subtype selective ligands (based on binding to brain adrenergic receptors). Specific binding was defined with appropriate unlabelled agonist and antagonist drugs in each case. Binding data were analysed by library programs of the PROPHET computer system. Subclass specificity was also determined indirectly by binding competition of the labelled ligand (at a three- to 10-fold Kd concentration) with increasing concentrations of 'cold' agonist or antagonist. Ligand binding parameters of unlabelled drugs were obtained from Dixon and Scatchard plots of the data. The adrenergic receptor density of iris-ciliary body is approx. 600 fmol mg-1 protein, of which 20-25% are primarily β2 receptors. Three distinct subpopulations of α-receptors, representing 10, 25 and 40-45% of the total, bind PRZ, WB and YOH, respectively, each with high specificity for its corresponding ligand but with 10- to 1000-fold lower specificity for the other two ligands. The majority of α-adrenergic receptors are of the α2-subtype. A small population of receptors are similar to vascular postsynaptic α1-receptors, while a larger subpopulation may have characteristics intermediate between α1- and α2-subtypes.
KW - adrenergic receptor subtypes
KW - iris-ciliary body
KW - ligand binding
KW - α-adrenergic receptors
KW - β-adrenergic receptors
UR - http://www.scopus.com/inward/record.url?scp=0021955160&partnerID=8YFLogxK
U2 - 10.1016/0014-4835(85)90009-0
DO - 10.1016/0014-4835(85)90009-0
M3 - Article
C2 - 2984032
AN - SCOPUS:0021955160
SN - 0014-4835
VL - 40
SP - 239
EP - 249
JO - Experimental Eye Research
JF - Experimental Eye Research
IS - 2
ER -